NXL
Nexalin Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.06
−5.60%Margins
Gross margin
-148.4%
EBITDA margin
-4129.0%
EBIT margin
-4202.5%
Net margin
-4139.4%
FCF margin
-2860.5%
-591.6%
Return on equity
-299.2%
Return on assets
-600.6%
Return on invested capital
0.06x
Asset turnover
-$6.1M
Cash from operations
$1.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026